PRESS

Supply chain security considerations for cannabis-based products

PUBLISHED BY CANNABIS HEALTH | NOVEMBER 2022

An Insider’s Look at the EU Cannabis Space

PUBLISHED BY CANNABIS PATIENT CARE | AUGUST 2021

Cannabinoid clinical trials – where, what and how?

PUBLISHED BY THE CANNABIS HEALTH | AUGUST 2021

The clinical trials roadmap

PUBLISHED BY THE CANNABIS HEALTH | MAY 2021

Don’t cross the Streams!

PUBLISHED BY THE CANNABIS SCIENTIST | APRIL 2021

The budding field of Cannabis Pharmaceuticals

PUBLISHED BY PHARMTECH | JANUARY 2021

Cannabis investment company Botanical
Holdings sets out its vision to list on London
Stock Exchange by 2021

PUBLISHED BY CANNABIS HEALTH NEWS | NOVEMBER 2020

“GACP and GMP in the Medicinal
Cannabis Industry – Is there a clear difference?”
Miguel fagundes

PUBLISHED BY CANNABIS SCIENCE & TECHNOLOGY | NOVEMBER/DECEMBER 2020

NEWS

Result of Annual General Meeting

PUBLISHED BY BOTANICAL HOLDINGS | JULY 2021

Botanical Holdings granted Zimbabwe hemp cultivation license

PUBLISHED BY IMAGE BOX COMMUNICATIONS | JULY 2021

Botanical Holdings commences construction of second medicinal cannabis growth and production site

PUBLISHED BY IMAGE BOX COMMUNICATIONS | JUNE 2021

Botanical Holdings awarded grant of up to €4.3 million for Portuguese operation

PUBLISHED BY IMAGE BOX COMMUNICATIONS | MAY 2021

Botanical Holdings secures GBP 4.5 million equity fundraising to accelerate its growth in the legal medicinal cannabis sector

PUBLISHED BY IMAGE BOX COMMUNICATIONS | MARCH 2021

BOTANICAL HOLDINGS PLC
3RD FLOOR, 25 GREEN STREET, LONDON W1K 7AX

RUA DA MISERICÓRIDA Nº 14,
6ºPISO E22 1249-038 LISBOA, PORTUGAL

© Copyright 2021 Botanical Holdings Plc